Part I. Background, Basic Science, and Evaluation of Lung Cancer

Incidence and Etiology: Shifting Patterns
Kim Josen, Richard Siegel, and David Kamp

Pathology of Lung Carcinoma
Mirela Stancu and N. Peter Libbey

Molecular Biology of Lung Cancer: A Primer
Mirela Stancu, Thomas King, and Abby Maizel

Molecular Biology of Human Lung Cancer: A Detailed Analysis
Xiangyang Dong and Li Mao

Techniques for the Diagnosis of Lung Cancer
Michael A. Passero

Lung-Cancer Staging
Richard Siegel, Kim Josen, and Sigmund Weitzman

Part II. Treatment: Non-Small-Cell Lung Cancer

Surgical Treatment for Early-Stage Non-Small-Cell Lung Cancer
Jeanne M. Lukanich and David J. Sugarbaker

The Evolution of the Multimodality Approach to Regionally Advanced Non-Small-Cell Lung Cancer
Gary M. Strauss

Treatment of Stage IV Non-Small-Cell Lung Cancer
Philip Bonomi and Lucio DiNunno.

New Treatments for Advanced Non-Small-Cell Lung Cancer
Gregory A. Masters

Part III. Treatment: Small-Cell Lung Cancer

Small-Cell Lung Cancer: From Natural History to Chemotherapy
Ritesh Rathore and Alan B. Weitberg

Small-Cell Lung Cancer: Surgery, Radiation and Newer Chemotherapy Approaches
Ritesh Rathore and Alan B. Weitberg

Part IV. Radiation Therapy: Novel Approaches

Novel Uses of Radiation Therapy in the Treatment of Carcinoma of the Lung
Thomas F. DeLaney

Part V. Practice Guidelines

A Guide to the Use of Practice Guidelines
Alan B. Weitberg

Alan B. Weitberg, MD, and a panel of internationally recognized basic scientists and clinicians present a comprehensive discussion of lung cancer, including a practice-oriented review of its diagnosis, evaluation, and treatment. The contributors offer not only an understandable description of its molecular origins-an essential key to developing future therapies and preventive measures-but also rigorously discuss well-tested approaches, as well as those that are currently being evaluated for future use in both the laboratory and clinic. The book also elucidates the creation and effective deployment of treatment guidelines introduced by third party payers to improve clinical outcomes, even while lowering healthcare costs.